Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2000

01-10-2000 | Meeting abstract

Introducing MRI into clinical breast practice

Author: S Field

Published in: Breast Cancer Research | Special Issue 2/2000

Login to get access

Excerpt

Although there are numerous publications regarding the value (and limitations) of MRI in the diagnosis of a variety of breast conditions, access to MRI in the UK is severely limited. Because prioritisation of all cases needing MRI is necessary, only those that will lead to a clear alteration in clinical management can be justified. Against this background, the current use of MRI in a busy symptomatic and screening practice will be presented and justified. …
Metadata
Title
Introducing MRI into clinical breast practice
Author
S Field
Publication date
01-10-2000
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr199

Other articles of this Special Issue 2/2000

Breast Cancer Research 2/2000 Go to the issue

Meeting abstract

Extending routine invitation to breast screening to the 65-69 year age group: report of the Scottish pilot study

Meeting abstract

Routine mammography for women aged 40-49 years: should mammography screening guidelines be changed in view of current research?

Meeting abstract

Image blur: back to basics

Meeting abstract

Implanted markers prior to neoadjuvant chemotherapy: preliminary report

Meeting abstract

Up the creek without a paddle

Meeting abstract

Stages of screen-detected breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits